TY - JOUR
T1 - Protective effects of blue light-blocking shades on phototoxicity in human ocular surface cells
AU - Niwano, Yoshimi
AU - Iwasawa, Atsuo
AU - Tsubota, Kazuo
AU - Ayaki, Masahiko
AU - Negishi, Kazuno
N1 - Funding Information:
Acknowledgements We are grateful to Dr Yoko Ozawa for providing the experimental shields and Dr Hideyuki Miyashita for technical and scientific contributions. Contributors YN conducted and reported the study. AI, MA and KT were involved in the design and conduct of the study. YN and MA designed the study. YN, MA, KN and KT reviewed the final version of the manuscript. YN, MA and KN are the guarantors. Funding The study was supported by a JSPS KAKENHI Grant-in-Aid for Scientific Research (C), 17K07788, 2017. Competing interests None declared. Patient consent for publication Not required. Provenance and peer review Not commissioned; externally peer reviewed.
Publisher Copyright:
© 2019 Author(s).
PY - 2019/5/1
Y1 - 2019/5/1
N2 - Objective Blue light hazards for retina and ocular surface have been repeatedly described and many protective methods are introduced for retina; however, no study has been conducted on ocular surface protection. The purpose of this in vitro study was to examine phototoxicity and shade protection after blue light irradiation in primary human cells of corneal surface origin. Methods and analysis Primary human cells of corneal surface origin were obtained from eye bank eyes. After blue light irradiation (405 nm) of these cells for 3 min, and a further 24 hours' incubation, surviving viable cells were assessed by the methyl thiazolyl tetrazolium assay. Simultaneously, cell viability was determined in wells covered by ultraviolet and blue light shades. Results Under subconfluent conditions, viable cells decreased by around 50% after blue light irradiation, compared with control cells without irradiation. The blue light phototoxicity was not blocked by the control shade, but the ultraviolet-blocking and blue light-blocking shades protected the cells from phototoxicity, producing a 30%-40% reduction (ultraviolet) and 15%-30% reduction (blue light) in viable cells. Conclusion These results indicate that blue light injures ocular surface cells and the cells are protected from damage by a shade. We recommend blue light protection to maintain ocular health, especially in high-risk populations, such as people with dry eye, contact lens users, the malnourished and the elderly.
AB - Objective Blue light hazards for retina and ocular surface have been repeatedly described and many protective methods are introduced for retina; however, no study has been conducted on ocular surface protection. The purpose of this in vitro study was to examine phototoxicity and shade protection after blue light irradiation in primary human cells of corneal surface origin. Methods and analysis Primary human cells of corneal surface origin were obtained from eye bank eyes. After blue light irradiation (405 nm) of these cells for 3 min, and a further 24 hours' incubation, surviving viable cells were assessed by the methyl thiazolyl tetrazolium assay. Simultaneously, cell viability was determined in wells covered by ultraviolet and blue light shades. Results Under subconfluent conditions, viable cells decreased by around 50% after blue light irradiation, compared with control cells without irradiation. The blue light phototoxicity was not blocked by the control shade, but the ultraviolet-blocking and blue light-blocking shades protected the cells from phototoxicity, producing a 30%-40% reduction (ultraviolet) and 15%-30% reduction (blue light) in viable cells. Conclusion These results indicate that blue light injures ocular surface cells and the cells are protected from damage by a shade. We recommend blue light protection to maintain ocular health, especially in high-risk populations, such as people with dry eye, contact lens users, the malnourished and the elderly.
KW - conjunctiva
KW - cornea
KW - ocular surface
UR - http://www.scopus.com/inward/record.url?scp=85066850662&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85066850662&partnerID=8YFLogxK
U2 - 10.1136/bmjophth-2018-000217
DO - 10.1136/bmjophth-2018-000217
M3 - Article
C2 - 31245609
AN - SCOPUS:85066850662
SN - 2397-3269
VL - 4
JO - BMJ Open Ophthalmology
JF - BMJ Open Ophthalmology
IS - 1
M1 - e000217
ER -